Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes
Objective Insulin-dependent diabetes can occur with immune checkpoint inhibitor (ICI) therapy. We aimed to characterize the frequency, natural history and potential predictors of ICI-induced diabetes.Research design and methods We reviewed 1444 patients treated with ICIs over 6 years at our cancer c...
| Published in: | BMJ Open Diabetes Research & Care |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Online Access: | https://drc.bmj.com/content/7/1/e000591.full |